Immunotoxin depletion of T cells and its effect on hematopoietic progenitor cells in human cord blood

Chinese Medical Journal

Volumn 114, Issue 4, 2001, Pages 355-359

  Xu, Manchun ^a   Lu, Shangen ^b   Shen, Beifen ^c   Li, Yan ^c  

^a GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Fetal blood; Hematopoietic stem cells; Immunotoxin; T cell depletion

Indexed keywords

CD5 ANTIGEN; CD8 ANTIGEN; IMMUNOTOXIN; RICIN;

ARTICLE; DRUG EFFECT; FETUS BLOOD; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; T LYMPHOCYTE;

ANTIGENS, CD5; ANTIGENS, CD8; FETAL BLOOD; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOTOXINS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; RICIN; T-LYMPHOCYTES;

EID: 0035323234     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Rubinstein P, Carrier C, Adamson J, et al. New York blood center's program for unrelated placental/umbilical cord blood transplantation 243 transplants in the first 3 years. Blood 1996; (Suppl 1): 142a.
2. 5) ricin A-chain immunotoxin. Transplantation 1987;43: 421-426.
3. Skolnick A. Application considered for immunotoxin in treatment of graft-vs-host disease. JAMA 1991;265:2041-2042.
4. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984;32:219-229.
5. Mickelson EM, Longton G, Anasetti E, et al. Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation. Tissue Antigens 1996;47:27-36.
6. Quinones RR, Youle RJ, Kiersey JH, et al. Anti-T cell monoclonal antibodies conjugated to ricin as potential reagents for human GVHD prophylaxis: effect on the generation of cytotoxic T cells in both peripheral blood and bone marrow. J Immunol 1984;132:678-683.
7. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
8. Keever CA, Abu Hajir M, Graf W, et al. Characterization of the alloreactivity and anti-leukemia reactivity of cord blood mononuclear cells. Bone Marrow Transplant 1995;15:407-419.
9. 8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia. Transplant Proc 1991;23:1695-1696.
10. Shen Bf, Yao ZJ, Zhang JZ, et al. Immunotoxin II: preparation of anti-human T cells monoclonal antibodies linked to ricin and its cytotoxic activity. Chin J Microbiol Immunol 1985;5:209-213.
11. Shen BF, Li Y, He YH, et al. Autologous bone morrow transplantation with marrow decontaminated by immunotoxins in the treatment of leukemia. J Monoclonal Antibody 1991;7:6-10.
12. Rubinstein P, Dobrila L, Rosenfied RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995;92: 10119-10122.